- Home
- PASW vs CLRB Comparison
PASW vs CLRB Comparison
Compare PASW & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASW
- CLRB
- Stock Information
- Founded
- PASW 2021
- CLRB 2002
- Country
- PASW Hong Kong
- CLRB United States
- Employees
- PASW N/A
- CLRB N/A
- Industry
- PASW Apparel
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- PASW Consumer Discretionary
- CLRB Health Care
- Exchange
- PASW Nasdaq
- CLRB Nasdaq
- Market Cap
- PASW 15.9M
- CLRB 12.8M
- IPO Year
- PASW N/A
- CLRB N/A
- Fundamental
- Price
- PASW $0.75
- CLRB $3.31
- Analyst Decision
- PASW
- CLRB Hold
- Analyst Count
- PASW 0
- CLRB 2
- Target Price
- PASW N/A
- CLRB N/A
- AVG Volume (30 Days)
- PASW 394.3K
- CLRB 343.2K
- Earning Date
- PASW 11-15-2025
- CLRB 11-17-2025
- Dividend Yield
- PASW N/A
- CLRB N/A
- EPS Growth
- PASW N/A
- CLRB N/A
- EPS
- PASW N/A
- CLRB N/A
- Revenue
- PASW $8,286,193.00
- CLRB N/A
- Revenue This Year
- PASW N/A
- CLRB N/A
- Revenue Next Year
- PASW N/A
- CLRB N/A
- P/E Ratio
- PASW N/A
- CLRB N/A
- Revenue Growth
- PASW N/A
- CLRB N/A
- 52 Week Low
- PASW $0.69
- CLRB $3.31
- 52 Week High
- PASW $5.40
- CLRB $66.00
- Technical
- Relative Strength Index (RSI)
- PASW N/A
- CLRB 28.66
- Support Level
- PASW N/A
- CLRB $3.70
- Resistance Level
- PASW N/A
- CLRB $4.10
- Average True Range (ATR)
- PASW 0.00
- CLRB 0.33
- MACD
- PASW 0.00
- CLRB -0.16
- Stochastic Oscillator
- PASW 0.00
- CLRB 0.00
About PASW Ping An Biomedical Co. Ltd. Ordinary Shares
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.